Novo Nordisk
NVO | NYSE
$41.60
-$0.03 (-0.07%)
At close: Nov 16, 2026, 4:00 PM ET
$41.55
-$0.05 (-0.12%)
After-hours:
Nov 16, 2026, 7:56 PM ET
Novo Nordisk Statistics
Key statistics explainedMarket Data
$183.39B
$1.3T
0.35
11.98M
4.42B
-0.54%
7.41%
NYSE
US6701002056
Price Performance
7.1%
-7.3%
-6.0%
-18.2%
-14.2%
-59.0%
-27.3%
7.1%
-12.7%
-4.6%
11.9%
Valuation
10.52
12.28
1.17
-4.37
3.54
3.90
5.56
25.46
25.46
9.24
3.89
7.92
7.00
27.96
9.0%
3.7%
3.7%
Financial Health
kr85.3B
kr134.48B
kr49.18B
kr599.16B
0.84
0.64
0.62
0.73
2.90
0.95
-63.22
3.81
5
Margins & Profitability
80.8%
46.1%
52.8%
33.9%
13.9%
13.9%
0.0%
N/A
Returns
18.9%
54.1%
30.2%
40.4%
23.2%
Historical Growth (CAGR)
15.8%
19.9%
11.6%
15.0%
20.5%
13.2%
-16.3%
-2.1%
1.8%
Analyst Forecasts
Hold
6
1.6%
2.3%
Feb 3, 2027
$0.10
-32.0%
$1.73B
-5.8%
Fair Value Estimates
$25.44
-38.9%
$81.14
95.0%
$40.00
-3.8%
Cash Flow
kr128.15B
kr46.32B
kr46.32B
$10.47
$28.97
38.5%
Income Statement
kr333.14B
kr273.21B
kr153.75B
kr185.02B
kr113.07B
$25.43
$4.84M
$1.64M
68,794
Dividends
$1.80
4.33%
7.1%
111.7%
111.7%
4.0%
Semi-Annual
Aug 17, 2026
Add to Watchlist
Select watchlists to add or remove NVO